Gavins FN - Search Results

1

Cell tracking technologies for acute ischemic brain injury.

Gavins FN, Smith HK. Gavins FN, et al. J Cereb Blood Flow Metab. 2015 Jul;35(7):1090-9. doi: 10.1038/jcbfm.2015.93. Epub 2015 May 13. J Cereb Blood Flow Metab. 2015. PMID: 25966948 Free PMC article. Review.

2

Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke.

Smith HK, Gil CD, Oliani SM, Gavins FN. Smith HK, et al. Among authors: gavins fn. FASEB J. 2015 May;29(5):2161-71. doi: 10.1096/fj.14-263160. Epub 2015 Feb 17. FASEB J. 2015. PMID: 25690650

3

Critical differences between two classical surgical approaches for middle cerebral artery occlusion-induced stroke in mice.

Smith HK, Russell JM, Granger DN, Gavins FN. Smith HK, et al. Among authors: gavins fn. J Neurosci Methods. 2015 Jul 15;249:99-105. doi: 10.1016/j.jneumeth.2015.04.008. Epub 2015 Apr 30. J Neurosci Methods. 2015. PMID: 25936850

4

Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke.

Smith HK, Omura S, Vital SA, Becker F, Senchenkova EY, Kaur G, Tsunoda I, Peirce SM, Gavins FNE. Smith HK, et al. FASEB J. 2018 May;32(5):2381-2394. doi: 10.1096/fj.201700746R. Epub 2017 Dec 21. FASEB J. 2018. PMID: 29269399 Free PMC article.

5

The potential of stem cell therapy for stroke: is PISCES the sign?

Smith HK, Gavins FN. Smith HK, et al. Among authors: gavins fn. FASEB J. 2012 Jun;26(6):2239-52. doi: 10.1096/fj.11-195719. Epub 2012 Mar 16. FASEB J. 2012. PMID: 22426119 Review.

6

Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation.

Stasiuk GJ, Smith H, Wylezinska-Arridge M, Tremoleda JL, Trigg W, Luthra SK, Morisson Iveson V, Gavins FN, Long NJ. Stasiuk GJ, et al. Among authors: gavins fn. Chem Commun (Camb). 2013 Jan 21;49(6):564-6. doi: 10.1039/c2cc37460a. Epub 2012 Dec 4. Chem Commun (Camb). 2013. PMID: 23208551 Free article.

7

Targeting the melanocortin receptor system for anti-stroke therapy.

Holloway PM, Smith HK, Renshaw D, Flower RJ, Getting SJ, Gavins FN. Holloway PM, et al. Among authors: gavins fn. Trends Pharmacol Sci. 2011 Feb;32(2):90-8. doi: 10.1016/j.tips.2010.11.010. Epub 2010 Dec 23. Trends Pharmacol Sci. 2011. PMID: 21185610 Review.

8

Potential therapeutic roles of stem cells in ischemia-reperfusion injury.

Barzegar M, Kaur G, Gavins FNE, Wang Y, Boyer CJ, Alexander JS. Barzegar M, et al. Stem Cell Res. 2019 May;37:101421. doi: 10.1016/j.scr.2019.101421. Epub 2019 Mar 16. Stem Cell Res. 2019. PMID: 30933723 Free article. Review.

9

Modeling Ischemic Stroke In Vitro: Status Quo and Future Perspectives.

Holloway PM, Gavins FN. Holloway PM, et al. Among authors: gavins fn. Stroke. 2016 Feb;47(2):561-9. doi: 10.1161/STROKEAHA.115.011932. Epub 2016 Jan 7. Stroke. 2016. PMID: 26742797 Free PMC article. Review. No abstract available.

10

Targeting the AnxA1/Fpr2/ALX pathway regulates neutrophil function, promoting thromboinflammation resolution in sickle cell disease.

Ansari J, Senchenkova EY, Vital SA, Al-Yafeai Z, Kaur G, Sparkenbaugh EM, Orr AW, Pawlinski R, Hebbel RP, Granger DN, Kubes P, Gavins FNE. Ansari J, et al. Blood. 2021 Mar 18;137(11):1538-1549. doi: 10.1182/blood.2020009166. Blood. 2021. PMID: 33512489 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page